REFERENCES
1. Phornphutkul C, Introne WJ, Perry MB, et al. Natural history of
alkaptonuria. N Engl J Med 2002;347:2111-2121.
2. Albers SE, Brozena SJ, Frank GL, Fenske NA. Alkaptonuria and
ochronosis: Case report and review. J Am Acad Dermatol 1992;27:609-614.
3. Thakur S, Markman P, Cullen H. Choice of valve prosthesis in a rare
clinical condition: Aortic stenosis due to alkaptonuria. Hear Lung Circ
2013;22:870-872.
4. Atalay A, Gocen U, Basturk Y, Kozanoglu E, Yaliniz H. Ochronotic
involvement of the aortic and mitral valves in a 72-year-old man. Texas
Heart Inst J 2015;42:84-86.
5. Atalay A, Polat V, Turhan N Tasoglu I. A rare cause of aortic valve
stenosis: Ochronosis. Turkish J Thorac Cardiovasc Surg 2018;261:467.
6. Capuano F, Emiliano A, Antonino R, et al. Blackish pigmentation of
the aorta in patient with alkaptonuria and Heyde’s syndrome. Aorta
(Stamford) 2014;2:74.
7. Ranganath LR, Jarvis JC, Gallagher JA. Recent advances in management
of alkaptonuria (invited review; Best practice article). J Clin Pathol
2013;66:367-373.
8. Introne WJ, Monique BP, James T, et al. A 3-year randomized
therapeutic trial of nitisinone in alkaptonuria. Mol Genet Metab
2011;103:307-314.
9. Ranganath LR, Khedr M, Milan AM, et al. Nitisinone arrests ochronosis
and decreases rate of progression of Alkaptonuria: Evaluation of the
effect of nitisinone in the United Kingdom National Alkaptonuria Centre.
Mol Genet Metab 2018;125:127-134.